MTS and colony formation assays demonstrated that SMURF2 knockdown enhanced proliferation of pancreatic cancer cells; however, co-knockdown of SMURF2 and CBX3 could not reverse this process (Fig. 6B-D). This evidence concerns the gene SMURF2 and familial pancreatic carcinoma.